Is a picture-perfect thrombectomy necessary in acute ischemic stroke?

Ching Jen Chen, Reda Chalhoub, Dale Ding, Jeyan S. Kumar, Natasha Ironside, Ryan T. Kellogg, Bradford B. Worrall, Andrew M. Southerland, Pascal Jabbour, Stacey Q. Wolfe, Adam S. Arthur, Nitin Goyal, Isabel Fragata, Ilko Maier, Charles Matouk, Jonathan A. Grossberg, Peter Kan, Clemens M. Schirmer, R. Webster Crowley, William J. AresChristopher S. Ogilvy, Ansaar T. Rai, Michael R. Levitt, Maxim Mokin, Waldo R. Guerrero, Justin R. Mascitelli, Albert J. Yoo, Richard Williamson, Andrew Walker Grande, Roberto Javier Crosa, Sharon Webb, Marios N. Psychogios, Robert M. Starke, Alejandro M. Spiotta, Min S. Park

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Background The benefit of complete reperfusion (modified Thrombolysis in Cerebral Infarction (mTICI) 3) over near-complete reperfusion (≥90%, mTICI 2c) remains unclear. The goal of this study is to compare clinical outcomes between mechanical thrombectomy (MT)-treated stroke patients with mTICI 2c versus 3. Methods This is a retrospective study from the Stroke Thrombectomy and Aneurysm Registry (STAR) comprising 33 centers. Adults with anterior circulation arterial vessel occlusion who underwent MT yielding mTICI 2c or mTICI 3 reperfusion were included. Patients were categorized based on reperfusion grade achieved. Primary outcome was modified Rankin Scale (mRS) 0-2 at 90 days. Secondary outcomes were mRS scores at discharge and 90 days, National Institutes of Health Stroke Scale score at discharge, procedure-related complications, and symptomatic intracerebral hemorrhage. Results The unmatched mTICI 2c and mTICI 3 cohorts comprised 519 and 1923 patients, respectively. There was no difference in primary (42.4% vs 45.1%; p=0.264) or secondary outcomes between the unmatched cohorts. Reperfusion status (mTICI 2c vs 3) was also not predictive of the primary outcome in non-imputed and imputed multivariable models. The matched cohorts each comprised 191 patients. Primary (39.8% vs 47.6%; p=0.122) and secondary outcomes were also similar between the matched cohorts, except the 90-day mRS which was lower in the matched mTICI 3 cohort (p=0.049). There were increased odds of the primary outcome with mTICI 3 in patients with baseline mRS ≥2 (36% vs 7.7%; p=0.011; p interaction =0.014) and a history of stroke (42.3% vs 15.4%; p=0.027; p interaction =0.041). Conclusions Complete and near-complete reperfusion after MT appear to confer comparable outcomes in patients with acute stroke.

Original languageEnglish (US)
Pages (from-to)111-116
Number of pages6
JournalJournal of NeuroInterventional Surgery
Volume14
Issue number2
DOIs
StatePublished - Feb 1 2022

Bibliographical note

Funding Information:
Competing interests MRL: Grants from the NIH (R01NS105692, R01NS088072, U24NS100654, UL1TR002319, R25NS079200) and the American Heart Association (18CDA34110295). Unrestricted educational grants from Medtronic, Stryker and Philips Volcano. Consultant for Medtronic. Minor equity/ownership interest in Proprio, Cerebrotech, Synchron. Adviser to Metis Innovative. JAG: Grants from the Georgia Research Alliance. Consultant for Cognition Medical. AJY: Grants from Medtronic, Cerenovus, Penumbra, and Stryker. Consultant for Penumbra and Cerenovus. Equity interest in Insera Therapeutics. RWC: Proctor for Medtronic and Cerenovus. AMS: Research support from Penumbra, Stryker, Medtronic, and Siemens. Consultant for Penumbra, Stryker, Terumo, and Arsenal. MM: Consultant for Medtronic and Cerenovus. Stock ownership in Serenity Medical, Synchron, and Endostream. RMS: Grants from the NREF, Joe Niekro Foundation, Brain Aneurysm Foundation, Bee Foundation, the NIH (R01NS111119-01A1, UL1TR002736, KL2TR002737), the National Center for Advancing Translational Sciences, the National Institute on Minority Health and Health Disparities, and Medtronic. Consultant for Penumbra, Abbott, Medtronic, InNeuroCo and Cerenovus. Others: None.

Publisher Copyright:
© 2022 BMJ Publishing Group. All rights reserved.

Keywords

  • stroke
  • thrombectomy

PubMed: MeSH publication types

  • Journal Article

Fingerprint

Dive into the research topics of 'Is a picture-perfect thrombectomy necessary in acute ischemic stroke?'. Together they form a unique fingerprint.

Cite this